| Product Code: ETC8284254 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Neuropathic Pain Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Neuropathic Pain Market - Industry Life Cycle |
3.4 Mexico Neuropathic Pain Market - Porter's Five Forces |
3.5 Mexico Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Mexico Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Mexico Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Mexico Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Mexico Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Mexico Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Mexico Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases leading to neuropathic pain |
4.2.2 Rising geriatric population in Mexico |
4.2.3 Growing awareness about treatment options for neuropathic pain |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in certain regions of Mexico |
4.3.2 High cost associated with neuropathic pain treatments |
4.3.3 Lack of skilled healthcare professionals specializing in neuropathic pain management |
5 Mexico Neuropathic Pain Market Trends |
6 Mexico Neuropathic Pain Market, By Types |
6.1 Mexico Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Mexico Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Mexico Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Mexico Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Mexico Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Mexico Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Mexico Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Mexico Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Mexico Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Mexico Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Mexico Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Mexico Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Mexico Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Mexico Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Mexico Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Mexico Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Mexico Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Mexico Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Mexico Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Mexico Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Mexico Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Mexico Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Mexico Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Mexico Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Mexico Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Mexico Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Mexico Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Mexico Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Mexico Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Mexico Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Mexico Neuropathic Pain Market Export to Major Countries |
7.2 Mexico Neuropathic Pain Market Imports from Major Countries |
8 Mexico Neuropathic Pain Market Key Performance Indicators |
8.1 Number of new neuropathic pain treatment options introduced in the market |
8.2 Patient satisfaction rates with neuropathic pain treatments |
8.3 Number of healthcare facilities offering specialized neuropathic pain management services |
9 Mexico Neuropathic Pain Market - Opportunity Assessment |
9.1 Mexico Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Mexico Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Mexico Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Mexico Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Mexico Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Mexico Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Mexico Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Mexico Neuropathic Pain Market - Competitive Landscape |
10.1 Mexico Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Mexico Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here